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However, not all individuals who experience childhood trauma 
develop depression and some individuals remain resilient even 
when exposed to additional stressors in adolescence or adulthood. 
Identifying biological and psychological factors that contribute to 
resilience after childhood trauma may suggest novel targets for the 
prevention of depression. A considerable number of studies sug-
gest that genetic factors moderate the relationship between early-
life stress and depression. Particular attention has been directed 
towards the role of a functional polymorphism in the promoter 
region of the serotonin transporter gene (5HTTLPR) in moderat-
ing the effects of childhood stress on adult depression (Caspi et al., 
2003; Brown and Harris, 2008), though results are inconsistent 
across studies (Brown and Harris, 2008). A recent meta-analy-
sis failed to corroborate the role of the 5HTTLPR in moderating 
the link between life stress and depression (Risch et al., 2009), 
though space constraints preclude a comprehensive  discussion of 
INTRODUCTION
It is now well-established that adverse experience early in life, such 
as childhood abuse, neglect or loss, dramatically increases the risk 
of developing major depression in adulthood, particularly in the 
context of additional challenge (Bifulco et al., 1991; McCauley 
et al., 1997; Dube et al., 2001; Chapman et al., 2004). Considerable 
evidence from preclinical animal models and clinical studies sug-
gests that stress early in life, during a period of heightened neural 
plasticity, leads to persistent hyperactivity of central nervous sys-
tem (CNS) corticotropin-releasing hormone (CRH) circuits and 
sensitization of hypothalamic-pituitary-adrenal (HPA) axis and 
autonomic nervous system responses to subsequent stress. (Ladd 
et al., 2000; Meaney and Szyf, 2005; Heim et al., 2008b; Lupien et al., 
2009; McGowan et al., 2009). These persistent neurobiological con-
sequences of early-life stress have been hypothesized to mediate the 
vulnerability to adult depression in victims of childhood trauma.
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this  controversial area. Our group investigated gene-environment 
interactions in depression risk focusing on variations of genes 
involved in regulating stress response systems (Bradley et al., 2008). 
Recently, we reported that a haplotype of the CRH receptor 1 
(CRHR1) gene, comprised of three single nucleotide polymor-
phisms (SNPs), exerts a protective effect against the development 
of depression after childhood trauma in two independent samples 
(Bradley et al., 2008). This ﬁ  nding has now been replicated in a sec-
ond independent study from England, representing a trans-ethnic 
replication (Polanczyk et al., 2009). In addition, Tyrka et al. (2009) 
have reported that the early trauma × CRHR1 genotype interac-
tion is reﬂ  ected in the cortisol response to combined dexametha-
sone/CRH stimulation. Thus, the CRHR1 gene may moderate the 
consequences of early adversity at the level of CRH-dependent 
neural transmission, though the functional relevance of the pro-
tective haplotype has not yet been ascertained.
In addition to the role of stress and genetic factors, there are 
important sex differences in the risk to develop depression. Major 
depression is twice as common in women as in men (Kessler et al., 
1993; Kessler, 2003). Moreover, women more frequently develop 
depression in response to childhood trauma compared to men 
(Weiss et al., 1999). Sex differences in the risk for stress-related 
depression have been hypothesized to be, in part, due to direct 
effects of circulating estrogens on the CNS (Ter Horst et al., 2009), 
including hypothalamic CRH neurons (Vamvakopoulos and 
Chrousos, 1993). Taken together, it appears that a complex interac-
tion between several intrinsic factors, i.e. genes and sex, and stressful 
experience underlie depression risk in most cases. Indeed, the CNS 
CRH system may be one substrate where the effects of these various 
dispositional and environmental factors are integrated.
Here we investigated interactions between the CRHR1 gene and 
sex in moderating the effects of childhood trauma on adult depres-
sion in an expansion of the previously described sample recruited 
in the waiting rooms of a large public urban hospital (Bradley et al., 
2008). In a second sample, recruited from the Atlanta metropolitan 
area, we ascertained effects of the CRHR1 gene and sex in moderat-
ing effects of early-life trauma at the level of an endophenotype of 
depression, i.e. neuroendocrine dysfunction. As a marker of neuroen-
docrine dysfunction, we measured cortisol response to a combined 
dexamethasone/CRH test, which is considered the most sensitive 
marker of HPA axis hyperactivity in depression (Ising et al., 2005). 
The dexamethasone/CRH test has previously been shown to be sen-
sitive to detect familial (Holsboer et al., 1995) and environmental 
depression risk, including risk due to childhood trauma (Heim et al., 
2008a). We hypothesized that a polymorphism of the CRHR1 gene 
moderates the effects of childhood trauma on adult depression and 
neuroendocrine dysfunction in a sex-speciﬁ  c manner.
MATERIALS AND METHODS
STUDY 1
Sample and sample recruitment
Data from this study were collected as part of a larger study inves-
tigating the roles of genetic and environmental factors in predict-
ing response to stressful life events in a predominantly African 
American, urban population of low socioeconomic status (Binder 
et  al., 2008; Bradley et  al., 2008). Research participants were 
approached while either waiting for their appointments in a general 
medical or obstetrical-gynecological clinic or while waiting with 
others who were scheduled for such appointments in a large public 
urban hospital. Subjects who indicated willingness to participate 
provided written informed consent, participated in a clinical inter-
view, and provided a salivary sample for DNA extraction (described 
below). Participants were reimbursed $15.00 for participation in 
this phase of the study. The presented data were obtained from the 
ﬁ  rst 1392 African American subjects and include the 560 individuals 
described in an earlier report (Bradley et al., 2008). All procedures 
in this study were approved by the Institutional Review Boards of 
the Emory University School of Medicine and Grady Memorial 
Hospital. Demographic and clinical features of the sample, strati-
ﬁ  ed by sex (62.2% female), are presented in Table 1.
Clinical assessment and psychometric instruments
Depressed mood was assessed with the 21-item self-report Beck 
Depression Inventory (BDI) (Beck et al., 1961). The BDI is a well 
validated, commonly used continuous measure of level of depres-
sive symptoms. In this sample, the BDI had a standardized alpha 
coefﬁ  cient (α) of 0.99 (M = 14.4, SD = 13.2) indicating high inter-
nal reliability. Symptoms of posttraumatic stress disorder (PTSD) 
were assessed using the modiﬁ  ed PTSD Symptoms Scale (PSS) 
Table 1 | Demographic and clinical features of men and women in study 1.
  Female   Male   Level of
 ( N = 639)  (N = 424)  signiﬁ  cance
Age in years (M, SD)  37 .8 (14.1)  44.4 (12.5)  p < 0.001
Education level (%)      p = 0.092
  <12th grade  26.0  24.9
 12th  grade  38.2  37 .4 
 GED  6.0  5.5 
  Some college or   20.8  19.0 
  technical school (Tech)
 College/tech  graduate  8.0  11.2 
 Graduate  school  0.9  2.1 
Relationship status (%)      p < 0.001
 Never  married  64.2  53.0
 Married  10.4  15.6 
 Divorced  11.1  20.8 
 Separated  6.9  8.0 
 Widowed  7 .4  2.6 
Household income/
 month  (%)      p = 0.004
  <500 $  38.7  39.6
 500–1000  $  26.3  24.8 
 1000–2000  $  26.4  22.7 
  >2000 $  8.7  12.9 
Employment status (%)  34.3  30.2  p = 0.16
BDI total score (M, SD)  13.4 (11.6)  11.3 (10.7)  p < 0.001
PSS total score (M, SD)  11.1 (11.7)  10.5 (11.4)  NS
Moderate-severe abuse (%)      p = 0.007
 Any  43.7  35.5
 Physical  22.2  21.0 
 Sexual  31.8  16.3 
 Emotional  20.0  17 .0 Frontiers in Behavioral Neuroscience  www.frontiersin.org  November 2009  | Volume 3  |  Article 41  |  3
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(Falsetti et al., 1993). Consistent with prior literature, we summed 
the PSS frequency items (“0: not at all” to “3:≥Five times a week”) 
to obtain a continuous measure of PTSD symptom severity rang-
ing from 0–51.
Childhood trauma was assessed using the 28-item version of the 
Childhood Trauma Questionnaire (CTQ) (Bernstein et al., 2003). 
The CTQ is a self-report inventory assessing ﬁ  ve types of childhood 
trauma, i.e. sexual, physical, and emotional abuse; and emotional 
and physical neglect. Studies have established the internal con-
sistency, stability over time, and criterion validity of the 28-item 
short form (Bernstein et al., 2003). The CTQ yields a total score 
and subscale scores for each type of childhood trauma. As prior 
research, we restricted analyses to the 3 abuse subscales (Bradley 
et al., 2008). Our data obtained from the abuse scales demonstrated 
high internal reliability (α = 0.99 for physical abuse; α = 0.94 for 
sexual abuse; α = 0.93 for emotional abuse; α = 0.98 for the total 
of these three scales). Bernstein and Fink (1998) established cut-off 
scores for none, mild, moderate, and severe exposure levels for each 
type of childhood trauma. Based on the CTQ data, we dichotomized 
participants into two groups for each of the three categories of 
abuse (Physical, Sexual, and Emotional Abuse). For each category 
of abuse, subjects with scores in the none-mild range were classiﬁ  ed 
as negative for exposure and subjects with scores in the moderate-
severe range were classiﬁ  ed as positive for exposure. Cut-off scores 
are ≥13 for Emotional Abuse, ≥10 for Physical Abuse, and ≥8 for 
Sexual Abuse. We next created a composite variable across the three 
abuse types, dividing participants into (1) those with no exposure 
to any moderate-severe abuse and (2) those with moderate-severe 
exposure to at least one type of abuse.
DNA extraction and genotyping
Saliva was collected into Scope mouthwash (N = 46) or into Oragene 
saliva kits (N = 1346) (DNAGenotek, Inc.). DNA was extracted 
using the Qiagen M48 system and the Purelink 96 Genomic DNA 
Kit by Invitrogen (Cat # K1821-04). SNP genotyping was performed 
as previously described (Binder et al., 2008; Bradley et al., 2008). 
Brieﬂ  y, we examined the CRHR1 SNP rs110402, as this SNP had 
shown the strongest interaction with early trauma to predict depres-
sion in our previous publication. This SNP is also in high linkage 
disequilibrium with the other associated SNPs and can thus serve 
as tag-SNP (Bradley et al., 2008). The SNP was genotyped using a 
TaqMan allelic discrimination assay (Livak, 1999) developed for use 
on the 7900HT instrument (Applied Biosystems, Forster City, CA, 
USA), using predesigned and validated TaqMan assay reagent kits 
containing one pair of PCR primers and one pair of ﬂ  uorescently 
labeled probes (Applied Biosystems; www.appliedbiosystems.com). 
PCR was performed in 5 µL reaction volumes in 384-well plates and 
contained 5 ng of DNA. The standard protocol provided with the 
kit was followed. Thermal cycler conditions were 95°C for 10 min, 
40 cycles of 95°C for 15 s and 60°C for 1 min. The SDS 2.3 software 
was used for allelic discrimination. The call rate for the rs110402 
was 99.2% and 0 discordances were observed across duplicates.
Data analysis
Of the 1392 subjects, 1213 had completed both the BDI as well as 
the CTQ, and 1234 high quality DNA samples were obtained. This 
resulted in 1059 individuals with no missing data and thus data 
from 635 women and 424 men were analyzed using the statistical 
software SPSS version 15. We used a general linear model to assess 
whether the genotype itself or in interaction with childhood abuse 
predicted current depressive symptoms. For CRHR1 variants, we 
investigated the effects of the most signiﬁ  cant CRHR1 SNP, as iden-
tiﬁ  ed in our previous study (Risch et al., 2009), rs110402, using an 
additive genetic model, with A being the protective allele. CRHR1 
genotypes were coded as 0, 1 and 2 (AA, AG and GG). Childhood 
abuse exposure was coded into a 2-level variable, as described above 
(0 = no type of moderate to severe child abuse; 1 = at least one 
type of moderate to severe child abuse). Analyses were stratiﬁ  ed 
by sex and adjusted for age, with rs110402 genotype, 2-level child 
abuse and their interaction term as predictors and the BDI total 
score as adults as outcome. In addition, we also investigated the 
same   interaction in the whole sample with presence or absence of 
moderate to severe physical-, sexual- or emotional abuse alone. 
Differences between men and women were evaluated using con-
tingency tables and general linear models. Analyses were 2-tailed 
with the level of signiﬁ  cance set at 0.05.
STUDY 2
Subjects
The sample of the neuroendocrine study was comprised of 78 
subjects (25 men and 53 women), aged 18–45 years (M = 29.7, 
SD = 7.5 years). Subjects were recruited as part of the larger Conte 
Center for the Psychobiology of Early-Life Trauma (MH58922) 
and, by deﬁ  nition, included subjects with/without exposure to 
childhood trauma before the age of 13 years and with/without a 
diagnosis of major depression. For this study, subjects were classi-
ﬁ  ed into those with versus those without childhood trauma expo-
sure, as described below. Exclusion criteria were current medical 
illness, lifetime psychosis or bipolar disorder, alcohol or substance 
abuse within 6 months or eating disorders within the past year. 
None of the participants was in current psychiatric treatment or 
currently received medications. Heavy smokers (>20 cigarettes/
day) were excluded. All subjects were recruited from responses 
to advertising in local newspapers and the transportation system 
and screened for eligibility. Eligible subjects were invited and paid 
for participation. After description of the study to participants, 
written informed consent was obtained. The study was approved 
by the Institutional Review Board of Emory University School 
of Medicine.
Methods
Subjects were admitted as inpatients to the Atlanta Clinical and 
Translational Science Institute, Emory University Hospital Clinical 
Interaction Site, which provides a standardized setting for clinical 
studies. Exposure to childhood trauma was assessed using the CTQ 
(Bernstein et al., 2003). Similar to Study 1, we used moderate-severe 
cut-off scores on each subscale to classify cases as positive or nega-
tive for a history of signiﬁ  cant trauma on each of the ﬁ  ve subscales 
(≥13 for Emotional Abuse; ≥10 for Physical Abuse; ≥8 for Sexual 
Abuse; ≥15 for Emotional Neglect; and ≥10 for Physical Neglect). 
(Bernstein and Fink, 1998). Cases classiﬁ  ed as positive on any one 
subscale were assigned to the group of cases with exposure to child-
hood trauma, whereas cases classiﬁ  ed as negative on all subscales 
were assigned to the group of cases without exposure to signiﬁ  cant Frontiers in Behavioral Neuroscience  www.frontiersin.org  November 2009  | Volume 3  |  Article 41  |  4
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childhood trauma. A total of 51 subjects were classiﬁ  ed as positive 
for a history of childhood trauma and 27 were classiﬁ  ed as negative 
for a history of childhood trauma.
On the ﬁ  rst day after hospital admission, subjects provided a 
blood sample for genotyping. Samples were assayed for the rs110402 
SNP of the CRHR1 gene, as described above. In this cohort, 28 sub-
jects carried the GG, 34 the AG, and 16 the AA genotype. Subjects 
were further categorized based on the presence of A alleles of the 
rs110402, resulting in 50 A-allele carriers (AA or AG genotype) and 
28 non-carriers (GG genotype).
The dexamethasone/CRH test was performed on the second 
inpatient day. In this test, a dose of 1.5 mg dexamethasone (Roxane 
Laboratories, Columbus, OH) was administered orally at 11 p.m. 
On the following day, antecubital venous catheters were inserted 
at 12 p.m. and kept patent by saline infusion. Post-dexametha-
sone blood samples were collected at 2 p.m. (−60 min), 2:30 p.m. 
(−30 min), and 3 p.m. (0 min). Immediately after the 3 p.m. sam-
ple, a bolus intravenous injection of 1 µg/kg ovine CRH (Ferring, 
Suffern, NY, USA) was administered. Blood samples were collected 
at 5, 15, 30, 60, 90, and 120 min after CRH injection. Blood was 
collected in EDTA tubes, placed immediately on ice, and centrifuged 
at 4ºC for 10 min at 3,000 rpm. Plasma was separated, coded and 
stored at −80ºC. Plasma cortisol concentrations were measured 
using a commercial radioimmunoassay (DiaSorin, Stillwater, MN, 
USA). Assay sensitivity was 0.04 µg/dl. Intra-assay variability was 
6.7% and interassay variability was 7.1%.
Data analysis
As noted above, subjects were grouped according to the following 
factors: History of childhood trauma (present vs. absent), sex (male 
vs. female), and CRHR1 rs110402 A-allele carrier status (GG vs. 
AG + AA). The protective/A allele carriers (genotypes AA and AG) 
were merged into one group to increase power, which was necessary 
due to the small sample size. Cortisol data were compared between 
various groups using repeated measures analysis of variance. The 
sample size did not allow for simultaneous testing of the 4-way 
or various 3-way interaction effects between childhood trauma, 
sex, genotype, and time. We therefore computed hypothesis-driven 
2-way interaction models to test for effects of interest: We ﬁ  rst tested 
the effects of rs110402 on cortisol response in the dexamethasone/
CRH test for women and men, separately, to test the hypothesis 
that the protective effect of the A allele occurs only in men. We then 
selected A allele carriers with and without exposure to childhood 
trauma and tested for sex by time interaction effects on cortisol 
response in order to test the hypothesis that the protective effect 
of the A allele occurs only in men exposed to childhood trauma, 
whereas this effect is not observed in non-exposed men or women 
exposed to childhood trauma. Signiﬁ  cant effects were conﬁ  rmed 
when controlling for current or lifetime major depression. Analyses 
were 2-tailed with the level of signiﬁ  cance set at 0.05.
RESULTS
STUDY 1
Sex differences in demographic and clinical variables
Demographic and clinical features of men and women in the sam-
ple are presented in Table 1. Signiﬁ  cant differences between men 
and women were observed for marital status and education, but 
not household income or employment status. The mean BDI total 
score was signiﬁ  cantly higher in women than in men, and women 
had experienced signiﬁ  cantly more childhood abuse than men. 
A proportion of 43.7% of women versus 35.5% of men had expe-
rienced any type of moderate-severe type of childhood abuse. This 
difference was carried by the higher prevalence of moderate-severe 
sexual abuse in women. Severity of PTSD symptoms did not dif-
fer between men and women. The severity of physical, sexual or 
emotional abuse was not signiﬁ  cantly different between men and 
women (data not shown). However, of the women with at least 
one type of moderate to severe abuse, 73.0 % had experienced 
sexual abuse, while this was only true for 43.0% of male partici-
pants. Physical abuse was the most common type of abuse in men 
(Table 1). In men who had been exposed to physical abuse, 30.4% 
had also experienced sexual abuse, while this proportion was much 
higher in females, with 62.8%.
Interaction between rs110402 and child abuse stratiﬁ  ed by sex
We tested the interaction of rs110402 genotype and any childhood 
abuse on current depressive symptoms in female and male sub-
jects, separately. Analyses were conducted in 424 male and 635 
female subjects (Figure 1). In women (Figure 1A), childhood abuse 
exposure was a signiﬁ  cant predictor (F1, 634 = 25.0, p < 0.0001), but 
there was neither a main effect of genotype nor an interaction 
effect of genotype by sex. In men (Figure 1B), however, there was 
a signiﬁ  cant main effect of childhood abuse exposure (F1, 423 = 8.20, 
p = 0.004) as well as a signiﬁ  cant interaction effect of childhood 
abuse exposure by rs110402 genotype (F2,423 = 3.50, p = 0.031), 
whereas there was no main effect of the genotype. Speciﬁ  cally, men 
homozygous for the A allele were most protected from developing 
depression after childhood abuse.
Interaction between rs110402 and different types of 
child abuse and role of sex
In the combined gender sample, only the interaction of physical 
abuse with rs110402 but not with the presence of emotional or 
sexual abuse was statistically signiﬁ  cant (Figure 2). We observed 
signiﬁ  cant effects of exposure to all three types of abuse on depres-
sive symptoms (physical abuse F1,1058 = 17.5, p < 0.001, sexual abuse 
F1,1058 = 11.7, p = 0.001, emotional abuse F1,1058 = 72.7, p < 0.001). 
A signiﬁ  cant main effect of rs110402 on depressive symptoms was 
seen in all three analyses (p < 0.05). The signiﬁ  cant interaction of 
the SNP with exposure to childhood abuse remained only with the 
presence of physical abuse (F2,1058 = 5.45, p = 0.004). To exclude 
that these results were due to different distribution of types of 
abuse between the sexes, we reran analyses in the male subsample 
and, again, only the interaction with physical abuse (F2,423 = 4.1, 
p = 0.018), but not the other two abuse types (F2,423 = 0.09, p = 0.91 
for sexual abuse and F2,423 = 1.43, p = 0.24 for emotional abuse) was 
statistically signiﬁ  cant. In women, none of the interactions reached 
statistical signiﬁ  cance.
STUDY 2
Sex difference in the effect of rs110402 on cortisol response
We ﬁ rst tested the hypothesis that there are sex differences in 
the effects of the protective CRHR1 rs110402 A allele on cor-
tisol response to the dexamethasone/CRH test. For statistical Frontiers in Behavioral Neuroscience  www.frontiersin.org  November 2009  | Volume 3  |  Article 41  |  5
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FIGURE 1 | Interaction of CRHR1 rs110402 genotype and childhood abuse 
exposure on current depressive symptoms in men (N = 424) and women 
(N = 635). Graph depicts mean (SEM) total BDI scores in subjects grouped 
according to rs110402 allele status (GG, AG, AA) and exposure to none-mild 
versus moderate-severe childhood abuse. (A) In men, there was a signiﬁ  cant 
main effect of childhood abuse exposure (F1, 423 = 8.20, p = 0.004) and a 
signiﬁ  cant interaction effect of rs110402 by childhood abuse exposure 
(F2,423 = 3.50, p = 0.031) on BDI scores. (B) In women, there was a signiﬁ  cant 
main effect of childhood abuse exposure on BDI score (F1, 634 = 25.0, 
p < 0.0001), but no signiﬁ  cant gene-environment interaction of rs110402 and 
childhood abuse exposure on BDI scores. The genotype distribution is given in 
the ﬁ  gure legend, with the ﬁ  rst number representing the N in the non-mild 
abuse group and the second number the N in the moderate to severe abuse 
exposure group.
  analyses, we pooled subjects carrying 1 or 2 A alleles (AG + AA) 
and   compared A allele carriers with GG carriers. For informa-
tive reasons, rs110402 subgroups (AA, AG, and GG) are presented 
separately in Figure 3. For women (Figure 3A), repeated meas-
ures ANOVA revealed a signiﬁ  cant main effect of the time factor, 
indicating similar increases in cortisol concentrations after CRH 
injection in all groups (F10, 500 = 68.486, p < 0.001). However, there 
was neither a signiﬁ  cant main effect of genotype, nor a genotype 
by time interaction effect, on plasma cortisol concentrations in 
women. For men (Figure 3B), repeated measures ANOVA revealed 
a signiﬁ  cant interaction effect of genotype by time (F10,230 = 2.225, 
p = 0.017): Men carrying one or two rs110402 A allele demon-
strated markedly decreased plasma cortisol responses in the dex-
amethasone/CRH test compared to men who were homozygous 
rs110402 GG-allele carriers. All effects remained signiﬁ  cant when 
controlling for current or lifetime major depression.
Sex differences in the effect of childhood trauma on cortisol response 
in rs110402 A allele carriers
We next selected carriers of the rs110402 A allele (AG or AA) to 
test the hypothesis that the effect of the A allele in decreasing cor-
tisol response in the dexamethasone/CRH test exclusively occurs in 
men with histories of childhood trauma, but not in men without 
such histories or women with or without childhood trauma history 
(Figure 4). For A allele carriers with childhood trauma exposure 
(Figure 4A), repeated measures ANOVA revealed a   signiﬁ  cant 
 interaction effect of sex by time (F10,300 = 3.652, p < 0.001),   indicating 
that female A allele carriers exposed to childhood trauma demon-
strated increased cortisol response in the dexamethasone/CRH test 
compared to male A allele carriers exposed to childhood trauma 
who demonstrated markedly low response. Among A allele carriers 
without childhood trauma exposure (Figure 4B), there only was a 
signiﬁ  cant main effect of the time factor (F10,160 = 15.173, p < 0.001), 
indicating similar increases in plasma cortisol concentrations in 
all groups. However, there were no sex differences in neuroendo-
crine response among A allele carriers in the absence of childhood 
trauma. All effects remained signiﬁ  cant when controlling for cur-
rent or lifetime major depression.
DISCUSSION
We evaluated interactions between the CRHR1 gene and sex in mod-
erating the well-known association between childhood trauma and 
adult depression (Bifulco et al., 1991; McCauley et al., 1997; Ladd 
et  al., 2000; Dube et  al., 2001; Chapman et  al., 2004). Previous 
research has suggested that allelic variation of the CRHR1 gene, par-
ticularly the rs110402 SNP located in intron 2 of the gene, protects 
against developing adult depression in the presence of moderate-
severe childhood abuse (Bradley et al., 2008; Polanczyk et al., 2009). 
Another line of research has provided longstanding evidence for a 
marked sex difference in the risk to develop depression, inasmuch as 
women more frequently suffer from depression in general (Kessler 
et al., 1993; Kessler, 2003) and more frequently develop depression in Frontiers in Behavioral Neuroscience  www.frontiersin.org  November 2009  | Volume 3  |  Article 41  |  6
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GG = 145 for the moderate-severe childhood abuse exposure group. (C) 
There was no signiﬁ  cant interaction of moderate to severe emotional abuse 
with rs110402 genotype. The genotype distribution was as follows: AA = 60, 
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FIGURE 3 | Effect of CRHR1 rs110402 on cortisol response in the 
dexamethasone/CRH test in women (N = 53) versus men (N = 25). Graph 
depicts mean plasma cortisol concentrations (µg/dl) in subjects grouped 
according to rs110402 allele status (GG, AG, AA). Subjects with 1 or 2 A 
alleles (AG or AA) were pooled for statistical analysis and compared with 
subjects carrying GG-alleles (see text). (A) In women, repeated measures 
ANOVA only revealed a signiﬁ  cant main effect for the time factor 
(F10, 500 = 68.486, p < 0.001), indicating similar increases in cortisol 
concentrations in all groups. (B) In men, repeated measures ANOVA revealed 
a signiﬁ  cant interaction of time by genotype (F10,230 = 2.225, p = 0.017), 
indicating decreased response in men carrying the A allele compared to men 
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to the dexamethasone/CRH test in the second sample. Thus, the 
observed genetic effects were more pronounced among subjects 
who were homozygous AA allele carriers than among subjects who 
were AG genotype carriers. It should be noted that we observed 
these concurring dose-response effects of rs110402 on depression 
and neuroendocrine function across two completely independent 
samples of subjects. These effects were present in spite of differ-
ences between the two studies: First, the urban hospital sample 
included in this report was comprised of African-Americans, 
whereas the second sample undergoing neuroendocrine testing 
was racially diverse. Second, the deﬁ  nition of the exposure vari-
able was different between the two studies. The urban hospital 
sample categorized subjects based on the presence or absence of 
moderate-severe sexual, physical or emotional abuse, whereas the 
sample with neuroendocrine measures additionally considered the 
presence or absence of emotional or physical neglect. Therefore, 
the non-exposed subjects in the second sample did not have any 
signiﬁ  cant childhood trauma, whereas the non-abused subjects 
in the hospital sample might have had experienced neglect to 
some extent. However, it was not possible in the latter sample to 
stratify based on CTQ neglect scales because these scores were 
not valid in this socioeconomically disadvantaged sample (see 
Bradley et al., 2008 for discussion).
In previous CRHR1 gene  ×  environment studies (Bradley 
et al., 2008; Polanczyk et al., 2009), a haplotype of allelic vari-
ations (TAT) across 3 SNPs within the CRHR1 gene, including 
rs242924, rs110402, and rs7209436, was particularly protective 
against developing depression. All three SNPs are in very high link-
age disequilibrium in both African American as well as European 
American samples, so that there is an almost complete overlap 
of rs110402 A allele carriers and TAT carriers. Interactions in the 
males of the expanded hospital sample or with physical abuse in the 
relation to childhood trauma (Weiss et al., 1999)compared to men. 
We therefore tested the hypothesis that the protective effect of the 
CRHR1 gene against developing depression after childhood trauma is 
speciﬁ  c to one of these sexes, and that one mechanism that mediates 
this effect involves a decrease CRH-dependent neurotransmission.
Our results are consistent with this hypothesis: We demonstrate 
in a large urban public hospital sample that the A allele of the 
rs110402 SNP is associated with decreased symptoms of depression 
among male subjects exposed to moderate-severe childhood abuse 
exposure, whereas this protective effects is not observed in female 
subjects with childhood abuse exposure. In a second sample of sub-
jects recruited from the Atlanta metropolitan area, we conﬁ  rm this 
sex by gene interaction at the level of an endophenotype of depres-
sion, i.e. cortisol response in the dexamethasone/CRH test, which 
is considered a sensitive marker of CRH/HPA axis hyperactivity in 
depression (Vamvakopoulos and Chrousos, 1993; Ter Horst et al., 
2009). Speciﬁ  cally, although allelic variation in the rs110402 SNP 
did not affect cortisol response to the dexamethasone/CRH test in 
women, male rs110402 A allele carriers had markedly decreased 
cortisol responses compared to male GG genotype carriers. A sec-
ond analysis within the sample of A allele carriers, revealed that 
women with childhood trauma exposure exhibited increased cor-
tisol response compared to men with childhood trauma exposure. 
There were no differences between male and female A allele carriers 
in the absence of childhood trauma. These results indeed suggested 
that the protective effect of rs110402 occurs speciﬁ  cally in men 
and becomes only effective in the presence of childhood trauma, 
resulting in decreased CRH-dependent neuroendocrine reactivity 
and, hence, decreased symptoms of depression.
Of note, the number of rs110402 A alleles appears to demon-
strate an inverse dose-response relationship with adult depressive 
symptoms in the hospital sample and the level of cortisol response 
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whole sample are thus in the same direction as the ones previously 
reported (Bradley et al., 2008). Due to the high degree of linkage 
disequilibrium, it is difﬁ  cult to pinpoint one of these SNPs as the 
functional variant. The region tagged by these variants spans a 
region from the 5′ putative promoter area to exon 3. Additional 
ﬁ  ne-mapping and re-sequencing will thus be necessary to identify 
the true functional variant.
While there are a number of preclinical studies that would 
support male-speciﬁ  c effects for this interaction (Sánchez et al., 
2005; Mueller and Bale, 2008; Weiser et al., 2008), the recently 
published study by Polanczyk et al. (2009) is at odds with the 
notion that the protective effect of CRHR1 rs110402 is speciﬁ  c 
to men. Polanczyk et al. replicate the early trauma × CRHR1 SNP 
interactions on adult depression in the 100% female E-Risk study 
from Great Britain, but not in the mixed-sex Dunedin study from 
New Zealand. In addition, in the latter study, no sex-speciﬁ  c inter-
actions were observed. In order to reconcile these results with 
our observations, we further investigated potential interactions 
between CRHR1 SNP and abuse types. Men and women in Study 
1 demonstrated differences in the frequency of the types of experi-
enced abuse. As shown in other cohorts (Gilbert et al., 2009), sexual 
abuse was much more frequent in women than in men in Study 
1, whereas the most frequent type of abuse in men was physical 
abuse, mostly in the absence of sexual abuse (Table 1). On the other 
hand, most women who had experienced physical abuse had also 
experienced sexual abuse. We thus re-analyzed the CRHR1 × abuse 
interaction with the speciﬁ  c subtypes of abuse and found that 
only physical abuse, but not emotional or sexual abuse, showed a 
signiﬁ  cant interaction with CRHR1 genotype on current depres-
sive symptoms. This could suggest that the observed male-speciﬁ  c 
effects in our cohort are driven by the fact that physical abuse is 
more prevalent in this group than in women. In addition, prior 
analyses of data (unpublished) from subjects in study 1 indicate 
that across both males and females, physical abuse has an earlier 
average self-reported age at time of ﬁ  rst experience than does sexual 
abuse and these analyses also indicate that across both males and 
female participants the self-reported frequency of physical abuse 
was higher than that of sexual abuse. Thus, given the high rates 
of physical abuse in male participants in study 1 it is possible that 
our ﬁ  nding of male-speciﬁ  c gene × environment interactions may 
be associated with an earlier onset and more frequent childhood 
stressor. These trauma- or trauma timing-speciﬁ  c interactions may 
in part be the underlying cause for the sex-speciﬁ  c neuroendocrine 
effects. Because of a small sample size and multiple exposures to 
different types of trauma, we could not verify this hypothesis in the 
second sample. Of note, the observation that the interaction of the 
CRHR1 polymorphism is most pronounced with physical abuse 
is in line with a previous study showing that long-term changes 
in cerebrospinal CRH are only seen with physical but not sexual 
abuse (Heim et al., 2008b).
A limitation of our study is that the size of the sample with 
neuroendocrine measures was too small to model 3- or 4-way inter-
action effects of CRHR1 gene, sex, childhood abuse, and time on 
cortisol concentrations. We also could not selectively assess the 
impact of the different types in that sample. Our results thus need 
to be veriﬁ  ed in larger samples modeling full interaction effects in 
future studies. The putative interaction between rs110402 genotype 
and childhood abuse in males were, however, in the same  direction 
as the ones reported by Tyrka et al. (2009). In both analyses, car-
riers of the protective A-allele exposed to childhood trauma dis-
played less HPA axis hyperactivity than individuals homozygous for 
the G-allele. Although we controlled for the impact of current or 
lifetime major depression, future studies in larger samples should 
include major depression and other Axis I disorders in a multi-
factorial model. However, the fact that similar ﬁ  ndings have been 
reported in individuals without any current psychiatric disorder 
(Tyrka et al., 2009) suggests that the reported interaction maybe 
independent of current psychiatric symptoms. In addition, the 
comparability of our endocrine ﬁ  ndings to the ones reported by 
Tyrka et al. (2009) further supports the trans-ethnic validity of 
this gene-environment interaction as our sample was of mixed 
ethnicity compared to the white non-Hispanic sample previously 
reported (Tyrka et al., 2009).
A second limitation is our reliance on retrospective and uncor-
roborated self-reports of childhood experiences. Problems con-
cerning the credibility of self-reports of childhood trauma include 
simple forgetting, non-awareness, non-disclosure, and reporting 
biases due to mood states (Hardt and Rutter, 2004). Moreover, 
declarative biographical memory before the age of 5 years is sparse 
perhaps because the hippocampus is not fully developed. Early 
trauma itself leads to hippocampal damage, which might impair 
recall of childhood experiences (Bremner, 1999). A recent meta-
analysis of studies using external corroboration of self-reports 
revealed that false negatives are more frequent than false positives, 
leading to downward biases in estimated associations between 
early adversity and outcome variables; the use of validated psy-
chometric instruments and focus on moderate-severe early trauma 
increased validity of self-reports (Hardt and Rutter, 2004). Of note, 
the CRHR1 gene × abuse interaction might also be dependent on 
the emotional connotation of the trauma experience that is evoked 
by the questions of the CTQ, but not other types of early trauma 
questionnaires that employ more factual questions (Polanczyk 
et al., 2009).
In conclusion, our results lend preliminary support of the 
hypothesis that the CRHR1 gene and sex interact in moderating 
effects of childhood trauma on adult depression. This gene-sex-
environment interaction was observed on the symptoms as well as 
endocrine level. Accordingly, we observed decreased cortisol reac-
tivity in male rs110402 A allele carriers with childhood trauma 
exposure. Further analyses revealed that these sex-speciﬁ  c interac-
tions may be carried by the type of experienced abuse. A signiﬁ  cant 
interaction was only observed with physical abuse and this abuse 
is the most common type of abuse in men in our samples and 
is experienced more frequently and at an earlier age than sexual 
abuse. In addition, physical, but not sexual abuse has been associ-
ated with long-term increases of CSF CRH concentrations (Heim 
et al., 2008b). These ﬁ  ndings underline the importance of an in-
depth characterization of childhood abuse and other environ-
mental stressors, including age of onset, frequency and severity in 
gene × environment predictors of psychopathology.
Overall, longitudinal studies are needed to provide informa-
tion on the causal relationship between childhood trauma and 
adult depression, as well as the moderators and mediators of 
this relationship. Such studies may not only have the potential to Frontiers in Behavioral Neuroscience  www.frontiersin.org  November 2009  | Volume 3  |  Article 41  |  9
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  reconcile inconsistent neurobiological ﬁ  ndings in depression, but 
will   ultimately help elucidate the pathophysiology, identify sub-
types, and devise strategies for the prevention and treatment of 
depression. Our ﬁ  ndings further emphasize the need to integrate 
complex interactions of the various dispositional and environmen-
tal contributors to depression.
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